Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
Document Type
Journal Article
Publication Date
6-14-2019
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
DOI
10.1007/s00198-019-05020-8
APA Citation
Bilezikian, J., Lin, C., Brown, J., Wang, A., Yin, X., Ebeling, P., Fahrleitner-Pammer, A., Franek, E., Gilchrist, N., Miller, P., Simon, J. A., Valter, I., Zerbini, C., Libanati, C., & Chines, A. (2019). Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, (). http://dx.doi.org/10.1007/s00198-019-05020-8
Peer Reviewed
1